|1.||Folch, Jaume: 2 articles (09/2009 - 05/2008)|
|2.||Pizarro, Javier G: 2 articles (09/2009 - 05/2008)|
|3.||Camins, Antoni: 2 articles (09/2009 - 05/2008)|
|4.||Pallàs, Mercè: 2 articles (09/2009 - 05/2008)|
|5.||Hallahan, Dennis E: 1 article (07/2014)|
|6.||Gao, Feng: 1 article (07/2014)|
|7.||Yuan, Liya: 1 article (07/2014)|
|8.||Garbow, Joel R: 1 article (07/2014)|
|9.||Thotala, Dinesh: 1 article (07/2014)|
|10.||Engelbach, John A: 1 article (07/2014)|
05/01/2008 - "Neuroprotective effects of SB-415286 on hydrogen peroxide-induced cell death in B65 rat neuroblastoma cells and neurons."
09/01/2009 - "A molecular study of pathways involved in the inhibition of cell proliferation in neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286."
09/01/2009 - "We examined the antiproliferative effects of two GSK-3 inhibitors, lithium and SB-415286, on B65 neuroblastoma cell line. "
07/15/2014 - "Effectiveness of SB415286 as a neuroprotectant against necrosis motivates potential clinical trials of it or other GSK-3β inhibitors."
07/15/2014 - "Mice treated with SB415286 showed significant protection from radiation-induced necrosis, as determined by in vivo MRI with histologic validation. "
07/15/2014 - "To quantify the effectiveness of SB415286, a specific inhibitor of GSK-3β, as a neuroprotectant against radiation-induced central nervous system (brain) necrosis in a mouse model. "
|3.||Stomach Neoplasms (Stomach Cancer)
|4.||Septic Shock (Toxic Shock Syndrome)
03/01/2006 - "The effects of the inhibitors of glycogen synthase kinase-3beta (GSK-3beta), TDZD-8 and SB 415286, which can substantially reduce the systemic inflammation associated with endotoxic shock in vivo, have now been investigated on the acute colitis provoked by trinitrobenzene sulphonic acid (TNBS) in the rat. "
|5.||Prostatic Neoplasms (Prostate Cancer)
01/15/2007 - "SOX9 message and protein levels in prostate cancer cells were increased by treatment with glycogen synthase kinase 3beta inhibitor (SB415286), and SOX9 was reduced when beta-catenin was down-regulated by small interfering RNA (siRNA), indicating that SOX9 expression in prostate cancer is regulated by Wnt/beta-catenin signaling. "
|1.||Glycogen Synthase Kinase 3
|4.||Glycogen Synthase (Synthase I)
|5.||glycogen synthase kinase 3 beta
|6.||Glycogen Synthase Kinases
|7.||Small Interfering RNA (siRNA)
|8.||Messenger RNA (mRNA)
|9.||Hydrogen Peroxide (Hydroperoxide)
|10.||4- benzyl- 2- methyl- 1,2,4- thiadiazolidine- 3,5- dione